Westfield Capital Management CO LP Rocket Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $19.9 Billion
- Q2 2024
A detailed history of Westfield Capital Management CO LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 4,327,922 shares of RCKT stock, worth $79.9 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
4,327,922
Previous 3,984,030
8.63%
Holding current value
$79.9 Million
Previous $107 Million
13.18%
% of portfolio
0.47%
Previous 0.57%
Shares
23 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$327 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$169 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$107 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.93MShares$72.6 Million1.67% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.4B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...